我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
198
25 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
2021
进行中(未招募)
3
1.5%
已完成
106
53.5%
Enrolling By Invitation
尚未招募
19
9.6%
招募中
35
17.7%
终止
2
1.0%
Unknown
29
14.7%
撤回
1
0.5%
暂无批准数据
- A study of 439 older adults found higher Akkermansia muciniphila levels associated with lower amyloid-beta accumulation in the brain, a key Alzheimer's hallmark. - Researchers identified 59 bacterial species linked to mild cognitive impairment or Alzheimer's, with closely related bacteria playing opposing roles in cognitive health. - A separate narrative review highlights that gut microbial dysregulation, including reduced SCFA-producing taxa, may begin during the preclinical stage of Alzheimer's before symptoms emerge. - Both reports emphasize that longitudinal studies are needed to clarify whether microbiome changes drive disease progression or result from neurodegeneration.